Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT04835519 · COMPLETED
Trial details
- NCT number
- NCT04835519
- Sponsor
- Beijing Boren Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-08
- Primary completion
- 2023-05-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.